Daniel M. Wechsler

2013

In 2013, Daniel M. Wechsler earned a total compensation of $8.2M as Executive Vice President, Company Group Chairman at Valeant Pharmaceuticals International.

Compensation breakdown

Option Awards$2,494,440
Salary$238,974
Stock Awards$5,000,384
Other$443,868
Total$8,177,666

Wechsler received $5M in stock awards, accounting for 61% of the total pay in 2013.

Wechsler also received $2.5M in option awards, $239K in salary and $443.9K in other compensation.

Rankings

In 2013, Daniel M. Wechsler's compensation ranked 598th out of 12,286 executives tracked by ExecPay. In other words, Wechsler earned more than 95.1% of executives.

ClassificationRankingPercentile
All
598
out of 12,286
95th
Division
Manufacturing
188
out of 4,614
96th
Major group
Chemicals And Allied Products
47
out of 1,466
97th
Industry group
Drugs
29
out of 1,160
98th
Industry
Pharmaceutical Preparations
27
out of 890
97th
Source: SEC filing on April 22, 2014.

Wechsler's colleagues

We found seven more compensation records of executives who worked with Daniel M. Wechsler at Valeant Pharmaceuticals International in 2013.

2013

Robert Chai-Onn

Valeant Pharmaceuticals International

Chief Legal Officer

2013

Laizer Kornwasser

Valeant Pharmaceuticals International

Group Chairman

2013

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2013

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

2013

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2013

Brian Stolz

Valeant Pharmaceuticals International

Senior Vice President and General Manager

2013

Pavel Mirovsky

Valeant Pharmaceuticals International

President and General Manager, Europe

You may also like